Home › Products › Infectious Disease › Viro 4 Kit Tablet
Viro 4 Kit Tablet
Salt Composition: ATAZANAVIR,LAMIVUDINE,RITONAVIR,TENOFOVIR DISOPROXIL FUMARATE
- Manufacturer: EMCURE PHARMACEUTICALS LTD
- Pack Size: 6 TABLET(s) IN A STRIP
- Dosage Form: TABLET
- Prescription Required
- Storage: Store at a temperature not exceeding 30°C. Keep away from moisture, heat, and light. Do not freeze the medicine. Keep out of the reach of children and pets.
₹582.00₹776.72
Inclusive of all taxes
Product Introduction
Viro 4 Kit tablet contains the active substances Atazanavir, Lamivudine, Ritonavir, and Tenofovir Disoproxil Fumarate, which are antiretroviral or antiviral medicines. This medicine is used to treat HIV (human immunodeficiency virus) infection. It acts as a nucleotide reverse transcriptase inhibitor (NRTI) and functions by inhibiting HIV reverse transcriptase, an enzyme essential for virus replication. This tablet has not been studied in patients aged over 65 years. Do not use Viro 4 Kit tablet if you have experienced allergic reactions to Atazanavir, Lamivudine, Ritonavir, Tenofovir Disoproxil Fumarate, or any other ingredient in this medicine. During treatment with Atazanavir, Lamivudine, Ritonavir, and Tenofovir Disoproxil Fumarate, your doctor may periodically monitor your blood counts, bone mineral density, cardiac function, liver function, and kidney function parameters to prevent serious complications. Inform your doctor if you have a history of heart failure (PR prolongation), hypersensitivity reactions (toxic skin eruptions or Stevens-Johnson syndrome), pancreatitis, bone disease (osteonecrosis—the death of bone tissue), fractures, liver disease (chronic hepatitis B or C), or kidney problems. Patients taking this medicine may develop immune reconstitution syndrome, diabetes mellitus, abnormal fat distribution, and hyperglycaemia. Viro 4 Kit tablet should not be given to patients with existing kidney problems. If you have lactose intolerance, notify your doctor before beginning treatment. Inform your doctor if you are planning to become pregnant or believe you may be pregnant. Breastfeeding is not recommended due to the potential risk of HIV transmission from mother to child.
Uses
Treatment of HIV infection
How it works
Atazanavir and Ritonavir inhibit the viral enzyme protease. Lamivudine and Tenofovir disoproxil fumarate inhibit the enzyme reverse transcriptase; inhibition of these enzymes blocks the reproduction of the virus and prevents the release of viral particles in the body to treat the HIV infection.
How to Use
Viro 4 Kit tablet are film-coated tablets. The usual recommended dosage of this medication is one tablet every day, with or without food. Your physician will choose the dosage and administration frequency based on the medical condition because it differs for each person. Do not crush, chew or break the tablet.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Serious: Pancreas problems Kidney damage Deep, rapid breathing Drowsiness Nausea, vomiting Lactic acidosis (excess lactic acid) Infection Increased liver enzymes Common: Headache Stomach pain Tiredness Bloating, flatulence Low phosphate levels in the blood Diarrhea Dizziness Joint pain Sickness Rash Weakness
Expert Tips
Inform your doctor about your underlying infections. If you have advanced HIV (AIDS), you may develop signs of infection and inflammation or worsen the signs of an existing infection once treatment is started. Report your doctor for side effects. It is very mandatory to tell your medical professional if you are consuming other medicines that may damage your kidneys. Always consume the dose recommended by your doctor. Viro 4 Kit tablet does not reduce the risk of passing on HIV to others through sexual contact or blood contamination. You must continue the medication to avoid this complication. Most patients experience asymptomatic increases in hyperbilirubinemia (increase in bilirubin).
References
- Goodman & Gilmanâs, The Pharmacological Basics of Therapeutics, Antiretroviral agents and treatment of HIV infection, 12th edition, 2011, 1632-1634.
- KD Tripathi, Essentials of Medical Pharmacology, Antiviral drugs, 7th edition, 2013, 809-810.
- Cipla Ltd, US Food and Drug Administration, [ Revised on October 2017] [ Accessed on 20th May 2023], https://www.accessdata.fda.gov/drugsatfda_docs/pepfar/206451PI.pdf
- Cipla (EU) Limited, Electronic Medicines Compendium (emc), [ Revised on Nov 2021] [ Accessed on 20th May 2023], https://www.medicines.org.uk/emc/files/pil.10500.pdf
Safety Advice
Pregnancy: Consult your doctor Notify your healthcare professional if you are pregnant or planning to have a baby think you may be pregnant. Your physician will conduct regular tests to monitor the development of your child. Ask for suggestions before taking the Viro 4 Kit tablet.
Lungs: Consult your doctor It is unknown whether the Viro 4 Kit tablet is safe for patients with lung problems. Inform your physician if you have any lung disease before starting the treatment. Contact your doctor if you experience any lung-related symptoms.
Breastfeeding: unsafe It is unsafe to breastfeed if you are with HIV infection. Consult your doctor for more information about Viro 4 Kit tablet.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.